Currently out of the existing stock ratings of William Woods, 8 are a BUY (100%).

William Woods

Work Performance Price Targets & Ratings Chart

Analyst William Woods, currently employed at B. RILEY, carries an average stock price target met ratio of 16.67% that have a potential upside of 25.66% achieved within 57 days. Previously, William Woods worked at BERNSTEIN, JPMORGAN.

William Woods’s has documented 16 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LFMD, LifeMD at 06-Aug-2026.

Wall Street Analyst William Woods

Analyst best performing recommendations are on LFMD (LIFEMD).
The best stock recommendation documented was for LFMD (LIFEMD) at 3/12/2024. The price target of $12 was fulfilled within 51 days with a profit of $3.62 (43.2%) receiving and performance score of 8.47.

Average potential price target upside

IMUX Immunic LFMD LifeMD

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 02-Mar-2026

$22

$15.03 (215.64%)

$22

1 months 11 days ago
(10-Sep-2026)

0/3 (0%)

$10.16 (85.81%)

Buy Since 17-Aug-2026

$45

$38.03 (545.62%)

$45

1 months 11 days ago
(10-Sep-2026)

0/2 (0%)

$33.16 (280.07%)

Buy Since 02-Sep-2025

$27

$20.03 (287.37%)

$4

4 months 29 days ago
(22-May-2026)

0/2 (0%)

$13.95 (106.90%)

Buy Since 11-May-2020

$22

$15.03 (215.64%)

5 months 7 days ago
(14-May-2026)

0/3 (0%)

$9.34 (73.78%)

Buy Since 16-Sep-2024

$40

6 months 6 days ago
(15-Apr-2026)

6/12 (50%)

$30.87 (338.12%)

64

Show more analysts

Please expand the browser size to see the chart

Which stock is William Woods most bullish on?

Potential upside of $20.03 has been obtained for IMUX (IMMUNIC)

Which stock is William Woods most reserved on?

Potential downside of $5.03 has been obtained for LFMD (LIFEMD)

What Year was the first public recommendation made by William Woods?

On 2024
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?